ArticleTranslational cancer research2026

Cinobufotalin reduces glioblastoma resistance to temozolomide by inhibiting the CCL5-mediated PI3K/Akt/mTOR signaling pathway.

Jiwei Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.